RT Journal Article
SR Electronic
T1 Medication Against Conflict
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.22.22272752
DO 10.1101/2022.03.22.22272752
A1 Andrea Berlanda
A1 Matteo Cervellati
A1 Elena Esposito
A1 Dominic Rohner
A1 Uwe Sunde
YR 2022
UL http://medrxiv.org/content/early/2022/03/23/2022.03.22.22272752.abstract
AB The consequences of successful public health interventions for social violence and conflict are largely unknown. This paper closes this gap by evaluating the effect of a major health intervention – the successful expansion of anti-retroviral therapy (ART) to combat the HIV/AIDS pandemic – in Africa. To identify the effect, we combine exogenous variation in the scope for treatment and global variation in drug prices. We find that the ART expansion significantly reduced the number of violent events in African countries and sub-national regions. The effect pertains to social violence and unrest, not civil war. The evidence also shows that the effect is not explained by general improvements in economic prosperity, but related to health improvements, greater approval of government policy, and increased trust in political institutions. Results of a counterfactual simulation reveal the largest potential gains in countries with intermediate HIV prevalence where disease control has been given relatively low priority.JEL-classification: C36, D47, I15, O10Competing Interest StatementThe authors have declared no competing interest.Funding StatementDominic Rohner gratefully acknowledges financial support from the ERC Starting Grant POLICIES FOR PEACE-677595. Uwe Sunde gratefully acknowledges financial support by Deutsche Forschungsgemeinschaft through CRC TRR 190 (project number 280092119).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data are aggregate at the country or region level and are openly, publicly and freely available.The main data source for conflict is SCAD (https://www.strausscenter.org/ccaps-research-areas/social-conflict/database/) and the main data source on HIV is World Bank (https://data.worldbank.org/indicator/SH.DYN.AIDS.ZS).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the manuscript are publicly available online. A replication dataset will be made available after publication in a journal.